These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36211462)

  • 41. MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis.
    Zheng J; Li X; Cai C; Hong C; Zhang B
    Cancer Manag Res; 2021; 13():3005-3016. PubMed ID: 33854371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
    Zhang M; Zeng J; Zhao Z; Liu Z
    Mol Carcinog; 2017 Mar; 56(3):821-832. PubMed ID: 27500472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.
    Chen X; Jiang Y; Huang Z; Li D; Chen X; Cao M; Meng Q; Pang H; Sun L; Zhao Y; Cai L
    Sci Rep; 2016 Jan; 6():19455. PubMed ID: 26781643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy.
    Ma Y; Yuwen D; Chen J; Zheng B; Gao J; Fan M; Xue W; Wang Y; Li W; Shu Y; Xu Q; Shen Y
    Int J Nanomedicine; 2019; 14():8121-8132. PubMed ID: 31632022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-27b suppresses epithelial-mesenchymal transition and chemoresistance in lung cancer by targeting Snail1.
    Zhang J; Hua X; Qi N; Han G; Yu J; Yu Y; Wei X; Li H; Chen X; Leng C; Liu Q; Lu Y; Li Y
    Life Sci; 2020 Aug; 254():117238. PubMed ID: 31887300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.
    Sun DM; Tang BF; Li ZX; Guo HB; Cheng JL; Song PP; Zhao X
    Sci Rep; 2018 May; 8(1):8007. PubMed ID: 29789623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
    Wang L; Shang X; Feng Q
    Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma.
    Liu T; Zhu J; Du W; Ning W; Zhang Y; Zeng Y; Liu Z; Huang JA
    Respir Res; 2020 Sep; 21(1):227. PubMed ID: 32873299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
    Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
    Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
    Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
    Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
    Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway.
    Yang W; Xiao W; Cai Z; Jin S; Li T
    Onco Targets Ther; 2020; 13():109-118. PubMed ID: 32021259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
    Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-125a attenuates the chemoresistance against ubenimex in non-small cell lung carcinoma via targeting the aminopeptidase N signaling pathway.
    Li C; Zhai W; Wan L; Li J; Huang A; Xing S; Fan K
    J Cell Biochem; 2020 Feb; 121(2):1716-1727. PubMed ID: 31595566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circ-SNAP47 (hsa_circ_0016760) and miR-625-5p are regulators of WEE1 in regulation of chemoresistance, growth and invasion of DDP-tolerant NSCLC cells via ceRNA pathway.
    Zou C; Rong F; Zeng Y; Zeng J; Wei R; Wei D
    Environ Toxicol; 2022 Feb; 37(2):224-236. PubMed ID: 34664776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy.
    Hua L; Zhu G; Wei J
    Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC).
    Zhao Y; Zheng R; Chen J; Ning D
    Cancer Cell Int; 2020; 20():289. PubMed ID: 32655321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
    Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.